Prawo i regulacje · 07/04/2022

Daridorexant Placed in Schedule IV by DEA

The US Drug Enforcement Administration has approved the placement of daridorexant, a new insomnia treatment, in Schedule IV of the Controlled Substances Act, allowing its commercial distribution as a lawful controlled substance.